HeartWare

Framingham, United States Founded: 2005 • Age: 21 yrs Acquired By Medtronic
Miniaturized ventricular assist devices are developed for heart failure treatment.
Request Access

About HeartWare

HeartWare is a company based in Framingham (United States) founded in 2005 was acquired by Medtronic in June 2016.. HeartWare has raised $12.38 million across 3 funding rounds from investors including Medtronic. The company has 547 employees as of December 31, 2015. HeartWare has completed 2 acquisitions, including CircuLite and World Heart Corporation. HeartWare operates in a competitive market with competitors including Sequana Medical, CVRx, Element Science, Ancora Heart and SynCardia, among others.

  • Headquarter Framingham, United States
  • Employees 547 as on 31 Dec, 2015
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Heartware, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.38 M (USD)

    in 3 rounds

  • Latest Funding Round
    $220 K (USD), Post-IPO

    Sep 25, 2009

  • Investors
  • Employee Count
    547

    as on Dec 31, 2015

  • Investments & Acquisitions
    CircuLite

    & 1 more

  • Acquired by
    Medtronic

    (Jun 27, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of HeartWare
Headcount 500-1000
Employee Profiles 11
Employee Profiles
People
Natalie Perez
Administrative Assistant
People
Kylie Jones
Clinical Specialist
People
Tyler Paszek
Sr. Regulatory Affairs Associate
People
Daniel Burkhoff
VP Medical Science

Unlock access to complete

Funding Insights of HeartWare

HeartWare has successfully raised a total of $12.38M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $220 thousand completed in September 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Post-IPO — $220,000
  • First Round

    (15 Aug 2007)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2009 Amount Post-IPO - HeartWare Valuation

investors

Aug, 2009 Amount Post-IPO - HeartWare Valuation

investors

Aug, 2007 Amount Series A - HeartWare Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in HeartWare

HeartWare has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medtronic. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Medical equipment for treating over 30 chronic diseases is developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by HeartWare

HeartWare has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CircuLite and World Heart Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Cardiac implants are developed for early-stage heart failure patients.
2004
Ventricular assist devices for heart failure patients are developed.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - HeartWare

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Heartware Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of HeartWare

HeartWare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, Element Science, Ancora Heart and SynCardia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable battery-powered pumps for ascites removal are developed.
domain founded_year HQ Location
Implantable technology for hypertension and heart failure is developed.
domain founded_year HQ Location
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
domain founded_year HQ Location
Minimally invasive ventriculoplasty system for heart failure and FMR
domain founded_year HQ Location
Total artificial hearts are developed for cardiac replacement therapy.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Heartware

Frequently Asked Questions about HeartWare

When was HeartWare founded?

HeartWare was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Where is HeartWare located?

HeartWare is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.

Is HeartWare a funded company?

HeartWare is a funded company, having raised a total of $12.38M across 3 funding rounds to date. The company's 1st funding round was a Series A of $12.38M, raised on Aug 15, 2007.

How many employees does HeartWare have?

As of Dec 31, 2015, the latest employee count at HeartWare is 547.

What does HeartWare do?

HeartWare was founded in 2005 in Framingham, United States, as a medical device company specializing in ventricular assist devices (VADs) for advanced heart failure patients. FDA approval was granted in 2012 for bridge-to-transplant therapy, while commercial availability has been established in Europe and Australia since 2009. Over 9,000 patients have been treated with the HeartWare Ventricular Assist System to date.

Who are the top competitors of HeartWare?

HeartWare's top competitors include Sequana Medical, CVRx and Adona Medical.

How many acquisitions has HeartWare made?

HeartWare has made 2 acquisitions, including CircuLite, and World Heart Corporation.

Who are HeartWare's investors?

HeartWare has 1 investor. Key investors include Medtronic.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available